[Peroral contraceptives and thromboembolism].
D000328:Adult; D001789:Blood Group Antigens; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003327:Coronary Disease / Q000139:chemically induced*; D004967:Estrogens / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced; D008525:Medroxyprogesterone / Q000009:adverse effects; D008875:Middle Aged; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced; D011655:Pulmonary Embolism / Q000139:chemically induced; D013268:Stimulation, Chemical; D013923:Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology; D013924:Thrombophlebitis / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced; D014280:Triglycerides
D001789:Blood Group Antigens; D003276:Contraceptives, Oral; D004967:Estrogens; D014280:Triglycerides; D004997:Ethinyl Estradiol; D008525:Medroxyprogesterone
Peroralni kontraceptivi i tromboembolizam.